Ryvu Therapeutics与BioNTech SE签署协议,支持其在波兰的癌症免疫疗法临床试验

投资观察
Sep 02, 2025

9月2日消息 - BioNTech SE宣布与Ryvu Therapeutics达成战略合作协议,为BioNTech SE在波兰开展的实验性癌症免疫疗法临床试验提供支持。

根据协议条款,Ryvu获得的订单总预算为295万欧元。该协议属于框架性质,Ryvu将根据BioNTech SE提交的独立订单执行具体服务项目。

这些订单将帮助BioNTech SE加速激活研究中心并为患者招募工作提供支持,涉及BioNTech SE在波兰实施的多个关键肿瘤学临床项目。

此次协议进一步扩大了双方现有的合作关系。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10